ArticleScientific reports2026
"Uropathogens and antimicrobial susceptibility patterns in urosepsis patients at kafr el sheikh University hospital: a cross-sectional study".
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urosepsis is a life-threatening consequence of urinary tract infections, often linked to obstruction, indwelling devices, and healthcare exposure. Increasing antimicrobial resistance among uropathogens complicates empirical therapy and adversely affects outcomes, making local surveillance essential for appropriate management. To determine the bacterial profile and antimicrobial susceptibility patterns of urosepsis cases admitted to Kafr El-Sheikh University Hospital. This cross-sectional study included 168 patients with confirmed urosepsis admitted to the Urology Unit between February 2024 and October 2025. Urosepsis was defined by identical organisms in urine and blood cultures with systemic sepsis and a SOFA score of ≥ 2. Cultures were processed using standard microbiological methods, with identification confirmed by biochemical testing and ATR-FTIR. Antimicrobial susceptibility testing was performed using the Kirby-Bauer method according to CLSI 2024 and verified by the BD Phoenix™ system. Multidrug-resistant (MDR) and ESBL-producing organisms were identified using standard criteria. The mean age of the patients was 56.2 ± 15.6 years, and 70.8% were male. Catheter-associated infections were identified in all cases (100%), reflecting the healthcare-associated nature of this cohort, while renal abscesses were detected in 26.2%. Gram-negative organisms predominated (90.5%), with Escherichia coli being the most frequently isolated pathogen. Statistical analysis revealed no significant demographic or clinical predictors of antimicrobial resistance patterns (p > 0.05). Gram-negative isolates showed higher susceptibility to carbapenems and fluoroquinolones. ESBL-producing isolates accounted for 24.34% and were susceptible to carbapenems. MDR isolates comprised 27.63% and showed high resistance to cephalosporins, piperacillin-tazobactam, and carbapenems. All gram-positive isolates were fully sensitive to vancomycin and teicoplanin. Catheter-associated urosepsis is mainly caused by resistant gram-negative pathogens. The high prevalence of ESBL and MDR strains underscores the need for early culture-guided therapy and continuous local antimicrobial surveillance to optimize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.